FDA Increases Warnings About Risk of Combining Opioids and Benzodiazepines

FDA Increases Warnings About Risk of Combining Opioids and Benzodiazepines
The Food and Drug Administration (FDA) has stepped up warnings about the dangers of combing opioid painkillers with benzodiazepine sedatives. The agency is requiring new warnings on labels for opioids such as oxycodone, hydrocodone and morphine, as well as for benzodiazepines such as alprazolam and diazepam. Xanax is a commonly used benzodiazepine. A total of 389 drugs are covered by the new warnings, The Wall Street Journal reports. β€œIt is nothing short of a public health crisis when you see a substantial increase of avoidable overdose and death related to two widely used drug classes being taken together,” FDA Commissioner Robert Califf, MD, said in a news release.
Rate this blog entry:
1918 Hits
0 Comments
×

Facing Addiction and The National Council on Alcoholism and Drug Dependence (NCADD) are proud to announce the merger of our organizations – creating a national leader in turning the tide on the addiction epidemic.
The merged organization will be called:

logo v2

Learn More